arrow
T

Takayoshi Oikawa

iwate medical university
H指数:13
被引数:539

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline Host Biomarkers and Six-Month Sustained Drug-Free Status After Atezolizumab–Bevacizumab for Hepatocellular Carcinoma: Exploratory Clinical Stratification Using PAN-DF Score

基线宿主生物标志物及阿替利珠单抗–贝伐珠单抗治疗肝细胞癌后六个月持续无药状态:使用PAN-DF评分的探索性临床分层

Cancers
IF4.4
2026-10-190
OA
Atezolizumab Plus Bevacizumab Treatment for Patients With Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer B2 Stage

阿特珠单抗联合贝伐珠单抗治疗巴塞罗那临床肝细胞癌B2期患者的疗效

2026-09-290
OAAI
A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage

一种预测BCLC晚期肝细胞癌患者生存时间的新模型

2025-10-150
OAAI
Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study

内皮功能障碍在肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗时高血压和蛋白尿中的潜在作用:一项前瞻性观察性试点研究

2025-04-170
PRE
Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen

优化7-on/7-off方案下不可切除肝细胞癌的卡博赞替尼剂量

CANCERS
IF4.4
2025-04-100
OA
Impact of shear wave elastography and attenuation imaging for predicting life-threatening event in patients with metabolic dysfunction-associated steatotic liver disease
2025-02-070
OAAI
A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage
2023-11-251
OAAI
Coincidental items in the definition of metabolic dysfunction-associated fatty liver are useful in identifying patients having significant fibrosis with fatty liver

代谢功能障碍相关脂肪肝定义中的巧合项可用于识别患有脂肪肝的显着纤维化患者

2023-06-152
PRE
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
2022-04-2014
OAAI
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy
2022-02-1529
OAAI